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Abstract
Background: Injectable artesunate (inj AS) is a new anti-malarial treatment recently
introduced in Sudan for the treatment of severe malaria . Inj AS has demonstrated its
superiority over injectable quinine in African and Asian patients. This study aimed to
evaluate the outcome of innovative teach-back tool kit session on the knowledge of
inj AS among the postgraduate nursing students at the University of Khartoum, Sudan.
Methods: This interventional pre–posttest studyincluded30postgraduatenursing
students selected though a full-coverage sampling method and meeting the selection
criteria. Data were collected using standardized self-administered questionnaire after
taking a written approval from the participants. The pretest included an initial
assessment followed by implementation of interactive session about new anti-malaria
treatment using an innovative teach-back toolkit, and the final assessment was
conducted after two weeks (posttest). The collected data were then analyzed and
interpreted using descriptive and inferential statistics based on the objective and
hypothesis of the study. A two-tailed p-value at 0.05 was considered as the level
of significance using SPSS version 20.
Results: Majority of the participants were aged between 20 and 30years; of them,
26 (87%) were female and 4(13%) male, and all of them had >1year of experience.
The findings of the study showed that half of the participants (15[50%]) had a good
knowledge score, 12 (40%) had a poor knowledge, and 3(10%) had a very poor
knowledge score in the pretest. However, the knowledge scores increased significantly
to 86.7% posttest, which is very good. The overall mean of pretest knowledge scores
regarding inj AS was7.4 with a statically significant difference (p=0.000). The mean
score was increased to 12 with a statically significant difference posttest (p=0.000).
Conclusion: There was a statistically significant improvement in the knowledge
scores of the postgraduate nursing students about inj AS after the implementation
of interactive teaching session using innovative teach-back tool kit.
Keywords: inj artesunate, teach back-toolkit, nursing students, session
How to cite this article: Sahar Ahmed, Eiman Eisa, Montaha Mohammed, and Samah Abdalla (2021) “The Effect of Innovative Teach-back Tool Kit
Session on the Postgraduate Nursing Students’ Knowledge About Injectable Artesunate,” Sudan Journal of Medical Sciences, vol. 16, Issue no. 1,





Received 14 January 2021
Accepted 10 March 2021
Published 31 March 2021
Production and Hosting by
Knowledge E
Sahar Ahmed et al. This
article is distributed under the





the original author and
source are credited.
Editor-in-Chief:
Prof. Mohammad A. M. Ibnouf
Sudan Journal of Medical Sciences Sahar Ahmed et al
1. Introduction
The World Health Organization (WHO) guidelines have recommended inj artesunate (inj
AS) as the preferred medicine for treating life-threatening conditions.
Teach-back is a communication strategy in which the patients are asked to reiterate
information provided to them using their own words, to confirm their understanding of
the information.Teach-back isalso used as an educational approach to educate both the
care givers and the patients about a new medication.The method is aproven teaching
and learning strategy that improves the quality of care and ensures that healthcare
professionals are educating patients and caregivers in an effective way to improve the
efficacy with new medications [1].
Teach-back is a practical technique to ensure that the health professional has clearly
explained a particular information to the patient and that the patient has understood
what they have been told. This technique goes beyond using questions such as “Is
that clear?” and “Have you understood everything?” Instead, the health professional
asks the patient to explain or demonstrate, using their own words, what has just been
discussed with them. Teach-back does not assess patient’s knowledge but it is an
effective technique to check how well the patient has understood the information
provided to them by a health professional [2].
A tool kit is a special set of tools that are kept together and are often used for
a particular purpose. A tool kit is the set of skills, abilities, knowledge, or other things
needed in order to do a particular task or job [3]. A study conducted in the United States
of America, aimed to improve patient outcomes using a tailored, evidence-based inter-
vention to develop, encourage, and support RNs’ abilities to educate andmonitor patient
and caregiver’s knowledge of new medications early in and throughout the patient’s
hospitalization, used teach-back method. Results of the study showed an increase in
hospital consumer assessment of healthcare provider and system (HCAHPS)scores and
confirmed that teach-back is an effective method to educate patients and caregivers
about new medications. Of note, since caregivers can recall the purpose and side
effects of medications more often than patients, caregivers or family members should
be included in patient education. As shown through this project, teach-back has been
approved as a teaching and learning strategy that improves the quality of care.
Malaria is a life-threatening disease caused by parasites that are transmitted to
people through the bites of infected female anopheles’ mosquitoes. It is preventable
and curable [4]. With an ongoing transmission of malaria in 95 countries and territories,
in 2018,WHO reported that 219 million cases of malaria occurred worldwide, which was
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significantly lower than the 239 million cases in 2010.Malaria occurred most frequently
in the WHO African region (92%), followed by the WHO South-East Asian region (5%)
and the Eastern Mediterranean region (2%) [5]. Approximately 300 cases of severe
malaria are reported in the US each year, most of them are acquired from travel to
malaria-endemic countries; cases of severe malaria should be treated with intravenous
(IV)antimalarial medication. However, in the US, the Food and Drug Administration(FDA)-
approved IV antimalarial and IV quinine have now been discontinued, and inj AS is the
first-line drug for the treatment of severe malaria [6].
Inj AS is a medication used to treat malaria and the intravenous form is preferred to
quinine for severe malaria. It is often used as a part of combination therapy, such as
artesunate + mefloquine, but it is not used for the prevention of malaria [7, 8].
Artesunate is a water-soluble hemisuccinate derivative of artemisinin indicated for
the treatment of severe falciparum malaria and initiated treatment of uncomplicated
falciparum malaria, when persistent vomiting precludes oral therapy. It comes in the
form of powder for injection in 20,60,120, and 160-mgvial with one 1-ml ampoule of
5% sodium bicarbonate and one 5-ml ampoule of 0.9%sodium chloride for slow IV
injection (3–5 min) or slow IM injection. Nurse must dissolve the powder in the entire
volume of 5% sodium bicarbonate and shake the vial until the solution becomesclear.
To add the 0.9%sodium chloride into the vial, 5ml of the 0.9%sodium chloride is added
to obtain 6mlof artesunate solution containing 10mg/ml for IV injection and 2ml of
0.9%sodium chloride is added to obtain 3ml of artesunate containing 20mg/ml. The
dosage and duration are as follows: childrenweighing <20 kg:3mg/kg/dose; children
weighing≥20kg and adult:2.4mg/kg/dose. The first dose is given on admission (H0), the
second 12 hr after the admission (H12), the third 24 hr after the admission (H24), and then
once daily. At least three doses should be administered parenterally;if the patient can
tolerate the oral route, change to an artemisinin-based combination. Of note, inj AS may
cause gastrointestinal disturbances, dizziness, headache, fever, muscle and joint pain,
pruritus,rashes in rare cases, QT interval prolongation, and post-treatment hemolytic
anemia (especially in cases of hyperparasitemia and in young children). However, there
is no contraindication for pregnancy and breast feeding [9].
In the past few years, many efficacy studies have been carried out in different
regions of Sudan and the findings have shown a decreasing efficacy to artesunate
+ sulphadoxine–pyrimethamine (AS+SP), particularly in Gadarif State (>10%), anda high
efficacy (>95%) of artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine
(DHAP).Moreover, Sudan’s malaria indicators survey) MIS) 2016 showed irrational use
of artemether intramuscular for treatment of uncomplicated malaria. Some published
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studies showed higher rate of non-adherence of healthcare providers to the treatment
guidelines and self-treatment. In response to this situation, the malaria technical advi-
sory committee (formed from national experts and partners) recommended the use of AL
as a first-line and DHAP as a second-line treatment for malaria in Sudan. The committee
also recommended the use of quinine or intravenous artesunate for the treatment of
severe malaria at hospital level [10].
A 2019 study in Tanzania showed the level of knowledge among healthcare providers
on the preparation of inj AS in public health facilities was low [11]. Hence, this study
was done to evaluate the effect of an innovative teach-back tool kit session on the
postgraduate nursing students’ knowledge about inj AS.
1.1. Research questions
1. What is the baseline knowledge of the postgraduate nursing students aboutin-
jectable artesunate (inj AS)?
2. What is the impact of an innovative teach-back tool kit session on postgraduate
nursing students’ knowledge about injectable artesunate (inj AS)?
1.2. Research hypotheses
H0:There will be no difference between pre- and posttest mean knowledge scores
toward injectable artesunate (inj AS) using an innovative teach-back tool kit after imple-
mentation of the interactive teaching session.
H1: There will be a significant difference between pre- and posttest mean knowledge
scores toward injectable artesunate (inj AS) using an innovative teach-back tool kit after
implementation of the interactive teaching session.
2. Materials and Methods
2.1. Design and setting
An interventional pre–posttest studywas conducted in the Faculty of Nursing Sciencesat
University of Khartoum, Sudan.
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2.2. Study population
The target population of the study was students pursuing master’s degree in nursing
sciences in all specialties. Because the students are attached to different hospitals, they
can easily transfer knowledge to their colleagues when they go back to their respective
hospitals.
2.3. Inclusion criteria
All students pursuing the master’sdegree of nursing sciences with all specialties in
batch12 in the Faculty of Nursing Sciences, University of Khartoum, Sudan.
2.4. Exclusion criteria
Master’s students attending workshop or training on new inj AS.
2.5. Sample size and technique
A total of 30 students participated in the study. They were selected through a full-
coverage sampling method.
2.6. Data collection methods
Data were collected by the researcher using a self-administered questionnaire after
conducting a pilot study to ensure the validity and reliability of the questionnaire.
The questionnaire consisted of two parts: part 1 included socio demographic data and
consisted of three variables (age, sex ,and practical experience ), part 2 consisted of
knowledge regarding inj AS and included 14 close-ended questions(Yes or No). Each
correct answer was given a score of “1” and a wrong answer was given a score of “0.”
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2.6.1. Structured interactive session
Contents of the session:
1. Definition of teach-back.
2. Use the tool kit.
3. Definition of malaria.
4. Information about artesunate injection.
5. Therapeutic action, indications, route of administrations, dosage and duration, and
contraindications of injAS.
Objective of the session
By the end of this presentation, every student will be able to:
1. Identify to the teach-back toolkit as a teaching strategy.
2. Recognize an overview about malaria and new antimalarial treatment (inj AS).
3. Should be able to calculate dose, indications, contraindications, and drug interac-
tions.
Interactive session was conducted in 60 min and comprised of a brief talk using
innovative teach-back tool kit and small group discussions.
2.7. Data analysis
Data were collected, coded, entered, and then analyzed using the statistical package
for social sciences (SPSS) using mean, standard deviation, paired t-test, and P-value.
3. Results
In this interventional pre–posttest study,30 nurses were included and the collected data
were tabulated, analyzed, and interpreted using description and inferential statistics
based on the objective of the study. Analysis was done based on the objective and
hypothesis of the study. A two-tailed p-value at 0.05 was considered as the level of
significance.
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Table 1 shows that the mean age of the participants was 25 years (age group 20–
30),most of the participants were female (26 [87%]), and all participants had a nursing
experience of >1 year.
TABLE 2: Students’ knowledge about injectable artesunate (injAS) (n=30).
No. Knowledge
aspects
Pretest Posttest Pretest1 and Posttest1 Paired
t-test
P-value
Mean SD Mean SD Mean SD















0.0667 0.25371 0.1333 0.34575 –0.06667 0.44978 0.423





0.6000 0.49827 1.0000 0.00000 –0.40000 0.49827 0.000




0.4000 0.49827 0.9333 0.25371 –0.53333 0.50742 0.000




0.5667 0.50401 0.9333 0.25371 –0.36667 0.49013 0.000





0.5000 0.50855 0.9000 –0.40000 0.30513 0.56324 0.001
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No. Knowledge
aspects
Pretest Posttest Pretest1 and Posttest1 Paired
t-test
P-value






0.4667 0.50742 0.9000 0.30513 –0.43333 0.56832 0.000






















































7.3667 2.79758 12.1333 1.59164 –4.76667 2.73777 .000
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Table 2 shows that the knowledge of the students about inj AS was poor and
that there was a considerable improvement after the implementation of the interactive
teaching session.
TABLE 3: Pre–posttest association between students’ demographic data and knowledge (n=30).









Table 3 shows that there was no difference in the knowledge between male and
female participants.
TABLE 4: Improvement in knowledge among participants(n=30).
Score Pretest Posttest
Frequency Percentage Frequency Percentage
11–14: Very good 3 10 26 86.,7
6–10:Good 15 50 4 13.3
<5:Poor 12 40 0 0
Table 3 shows the total pre- and posttest knowledge of the respondents about inj
AS and the significant improvement in their knowledge after the implementation of
interactive session.
4. Discussion
Inj AS is a new anti-malarial treatment recently introduced in Sudan. It is used to treat
severe malaria. This study aimed to evaluate the effect of an innovative teach-back
tool kit session on the knowledge of the students pursuing master’s degree in nursing
sciences about inj AS and included 30 nurses. In the pretest, an initial assessment done
followed by implementation of interactive session about inj AS using an innovative teach-
back toolkit. A final assessment was conducted after two weeks (posttest) to evaluate
the effectiveness of the interactive session.
Themean pretest knowledge regarding the question about better treatment of severe
malaria was 1.6 and that of posttest was 1.2. The association between the pre- and
posttest was P = 0.4, which was not significant (0.019>0.05) and the participants thought
that quinine was better than artesunate as artesunate injections are unavailable in
Sudan and are also expensive, as shown in Table 1. However, contrary to our results,
previous studies reveled that inj AS gains advantage over other anti-malarial injections
in treating severe malaria due to its tolerable side effects and high parasitic clearance.
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It is also associated with low mortality in both children and adults with fewer side effects
compared to quinine [11].
However, in Tanzania mainland, inj AS is the first drug of choice while artemether
injection is the alternative for treating severe malaria in the general population and
quinine injection is the first-line treatment of severe malaria in pregnant women ([12].
The mean pretest knowledge about question regarding injectable artesunate given
rapidly was 0.1 and that that of posttest was 0.1. The association between pre- and
posttest was P = 0.1, which was not significant (423>0.05), as shown in Table 1.
The present study confirmed that there was a considerably low level of knowledge
concerning different formulas, preparation, calculation, and administration following the
protocol in pretest. This is in line with a Turkish study that found a low level of knowledge
among nurses in administering IM medicines at ventrogluteal site [13]. However, the
nurses’ knowledge improved significantly after implementing the teaching session.
In general, the total pre- and posttest knowledge regarding inj AS is significant with
the mean total of pretest 7.4 and posttest12 and the association between the total pre-
and posttest was –4.8 which is significant (p=0.000). In addition, half of the participants,
that is 15, (50%) had a a good knowledge score and12 (40%) had a poor knowledge
in pretest which increased significantly to 86.7% posttest. In comparison with the study
done in Tanzania which showed that the level of knowledge on the preparation of
inj AS for the treatment of severe malaria among public healthcare providers in all
municipalities of Dar-al-Salaam region, the majority of HCP had low knowledge (82.5%)
on how inj AS was prepared and only few had moderate (11.9%)-to-high knowledge
(5.6%) despite its high availability in healthcare facilities and preference by HCP [11].
The present study revealed that knowledge scores of participants increased signifi-
cantly after the implementation of interactive teaching session using innovative teach-
back tool kit.
Therefore ,nurses in clinical practice need to adopt teach-back tool kit as a teaching
strategy for any new treatment. In addition, hospital policy-makersmust put informational
posters for any new treatment around the hospital compound which could aid in
recalling the treatment protocols. In the same direction, an Italian study showed the
efficacy of posters, protocols, and brochures in reducing medication errors for IV drugs
administration [14].
The study reveals that even with the utility of these orientation resources, there
is a high likelihood of errors due to negligence of some vital issues that might be
emphasized during training. This will possibly be reflected by the fact that almost half
of the HCP knew the flow pattern to follow when preparing artesunate injection and the
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difference between the IM and IV artesunate preparation but could not respond correctly
as what to do when the mixture does not mix up, when to discard the prepared solution,
or the correct dose by body weight [11].
4.1. Hypothesis Testing
H0: There will be no difference between pre- and posttest mean knowledge scores
regarding the new anti malarial treatment injectable artesunate (inj AS) using an inno-
vative teach-back tool kit.
The aforementionednull hypothesis is rejected, and the alternative hypothesis H0 is
accepted, since there was a significant differencebetween the pre- and posttest mean
knowledge scores,p < 0.000, as shown in Table 1.
H1: There will be a significant difference between pre- and posttest mean knowledge
scores toward injectable artesunate (inj AS) using an innovative teach-back tool kit after
implementation of the interactive teaching session.
Hypothesis H1 is accepted as there was a significant improvement in the knowledge
scores of post graduate students after the administration of the interactive teaching
session.
5. Conclusion
There was statistically significant improvement in the knowledge scores of the post-
graduate nursing students about Inj AS after the implementation of interactive teaching
session using the innovative teach-back tool kit.
Limitations
1. The study was limited to students pursuing master’s degree in nursing sciences
in the Faculty of Nursing, University of Khartoum, Sudan.
2. The sample for the study was limited to 30 students only .Future studies must be
conducted in hospital settings.
3. Inadequate literature and studies to make comparisons with.
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Strengths
To the best of our knowledge, no previous study has been conducted on the current
topic in Sudan.
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